Diabetic foot MRI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→MRI) |
||
| Line 6: | Line 6: | ||
==MRI== | ==MRI== | ||
*[[Magnetic resonance imaging]] ([[Magnetic resonance imaging|MRI]] is specific for [[osteomyelitis]] [[diagnosis]].<ref name="pmid9431370">{{cite journal| author=Lipsky BA| title=Osteomyelitis of the foot in diabetic patients. | journal=Clin Infect Dis | year= 1997 | volume= 25 | issue= 6 | pages= 1318-26 | pmid=9431370 | doi=10.1086/516148 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9431370 }} </ref> | *[[Magnetic resonance imaging]] ([[Magnetic resonance imaging|MRI]]) is specific for [[osteomyelitis]] [[diagnosis]].<ref name="pmid9431370">{{cite journal| author=Lipsky BA| title=Osteomyelitis of the foot in diabetic patients. | journal=Clin Infect Dis | year= 1997 | volume= 25 | issue= 6 | pages= 1318-26 | pmid=9431370 | doi=10.1086/516148 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9431370 }} </ref> | ||
*[[Magnetic resonance angiography]] ([[Magnetic resonance angiography|MRA]]) can be helpful in evaluation of [[Limb (anatomy)|limb]] [[perfusion]]. Nevertheless it has limited spatial resolution and reports could be influenced by previous [[stents]] or [[Implant (medicine)|implants]].<ref name="LepäntaloApelqvist2011">{{cite journal|last1=Lepäntalo|first1=M.|last2=Apelqvist|first2=J.|last3=Setacci|first3=C.|last4=Ricco|first4=J.-B.|last5=de Donato|first5=G.|last6=Becker|first6=F.|last7=Robert-Ebadi|first7=H.|last8=Cao|first8=P.|last9=Eckstein|first9=H.H.|last10=De Rango|first10=P.|last11=Diehm|first11=N.|last12=Schmidli|first12=J.|last13=Teraa|first13=M.|last14=Moll|first14=F.L.|last15=Dick|first15=F.|last16=Davies|first16=A.H.|title=Chapter V: Diabetic Foot|journal=European Journal of Vascular and Endovascular Surgery|volume=42|year=2011|pages=S60–S74|issn=10785884|doi=10.1016/S1078-5884(11)60012-9}}</ref> | *[[Magnetic resonance angiography]] ([[Magnetic resonance angiography|MRA]]) can be helpful in evaluation of [[Limb (anatomy)|limb]] [[perfusion]]. Nevertheless it has limited spatial resolution and reports could be influenced by previous [[stents]] or [[Implant (medicine)|implants]].<ref name="LepäntaloApelqvist2011">{{cite journal|last1=Lepäntalo|first1=M.|last2=Apelqvist|first2=J.|last3=Setacci|first3=C.|last4=Ricco|first4=J.-B.|last5=de Donato|first5=G.|last6=Becker|first6=F.|last7=Robert-Ebadi|first7=H.|last8=Cao|first8=P.|last9=Eckstein|first9=H.H.|last10=De Rango|first10=P.|last11=Diehm|first11=N.|last12=Schmidli|first12=J.|last13=Teraa|first13=M.|last14=Moll|first14=F.L.|last15=Dick|first15=F.|last16=Davies|first16=A.H.|title=Chapter V: Diabetic Foot|journal=European Journal of Vascular and Endovascular Surgery|volume=42|year=2011|pages=S60–S74|issn=10785884|doi=10.1016/S1078-5884(11)60012-9}}</ref> | ||
*[[Magnetic resonance angiography]] ([[Magnetic resonance angiography|MRA]]) has 94% [[Specificity (tests)|specificity]] and [[Sensitivity (tests)|sensitivity]] for [[peripheral arteries]].<ref name="SchaperAndros2012">{{cite journal|last1=Schaper|first1=N. C.|last2=Andros|first2=G.|last3=Apelqvist|first3=J.|last4=Bakker|first4=K.|last5=Lammer|first5=J.|last6=Lepantalo|first6=M.|last7=Mills|first7=J. L.|last8=Reekers|first8=J.|last9=Shearman|first9=C. P.|last10=Zierler|first10=R. E.|last11=Hinchliffe|first11=R. J.|title=Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot|journal=Diabetes/Metabolism Research and Reviews|volume=28|year=2012|pages=218–224|issn=15207552|doi=10.1002/dmrr.2255}}</ref><ref name="pmid11255390">{{cite journal| author=Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM| title=Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. | journal=JAMA | year= 2001 | volume= 285 | issue= 10 | pages= 1338-45 | pmid=11255390 | doi=10.1001/jama.285.10.1338 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11255390 }} </ref> | |||
*Usage of [[Contrast medium|contrast materials]] such as gadolinium is not recommended in [[diabetes|diabetic]] [[patients]] due to high risk of [[Renal insufficiency|renal failure]].<ref name="PrinceZhang2008">{{cite journal|last1=Prince|first1=Martin R.|last2=Zhang|first2=Honglei|last3=Morris|first3=Michael|last4=MacGregor|first4=Jennifer L.|last5=Grossman|first5=Marc E.|last6=Silberzweig|first6=Jeffrey|last7=DeLapaz|first7=Robert L.|last8=Lee|first8=Henry J.|last9=Magro|first9=Cynthia M.|last10=Valeri|first10=Anthony M.|title=Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers|journal=Radiology|volume=248|issue=3|year=2008|pages=807–816|issn=0033-8419|doi=10.1148/radiol.2483071863}}</ref><ref name="RydahlThomsen2008">{{cite journal|last1=Rydahl|first1=Casper|last2=Thomsen|first2=Henrik S.|last3=Marckmann|first3=Peter|title=High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent|journal=Investigative Radiology|volume=43|issue=2|year=2008|pages=141–144|issn=0020-9996|doi=10.1097/RLI.0b013e31815a3407}}</ref> | *Usage of [[Contrast medium|contrast materials]] such as gadolinium is not recommended in [[diabetes|diabetic]] [[patients]] due to high risk of [[Renal insufficiency|renal failure]].<ref name="PrinceZhang2008">{{cite journal|last1=Prince|first1=Martin R.|last2=Zhang|first2=Honglei|last3=Morris|first3=Michael|last4=MacGregor|first4=Jennifer L.|last5=Grossman|first5=Marc E.|last6=Silberzweig|first6=Jeffrey|last7=DeLapaz|first7=Robert L.|last8=Lee|first8=Henry J.|last9=Magro|first9=Cynthia M.|last10=Valeri|first10=Anthony M.|title=Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers|journal=Radiology|volume=248|issue=3|year=2008|pages=807–816|issn=0033-8419|doi=10.1148/radiol.2483071863}}</ref><ref name="RydahlThomsen2008">{{cite journal|last1=Rydahl|first1=Casper|last2=Thomsen|first2=Henrik S.|last3=Marckmann|first3=Peter|title=High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent|journal=Investigative Radiology|volume=43|issue=2|year=2008|pages=141–144|issn=0020-9996|doi=10.1097/RLI.0b013e31815a3407}}</ref> | ||
==References== | ==References== | ||
Revision as of 14:45, 9 July 2021
|
Diabetic foot Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diabetic foot MRI On the Web |
|
American Roentgen Ray Society Images of Diabetic foot MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]
Overview
MRI
- Magnetic resonance imaging (MRI) is specific for osteomyelitis diagnosis.[1]
- Magnetic resonance angiography (MRA) can be helpful in evaluation of limb perfusion. Nevertheless it has limited spatial resolution and reports could be influenced by previous stents or implants.[2]
- Magnetic resonance angiography (MRA) has 94% specificity and sensitivity for peripheral arteries.[3][4]
- Usage of contrast materials such as gadolinium is not recommended in diabetic patients due to high risk of renal failure.[5][6]
References
- ↑ Lipsky BA (1997). "Osteomyelitis of the foot in diabetic patients". Clin Infect Dis. 25 (6): 1318–26. doi:10.1086/516148. PMID 9431370.
- ↑ Lepäntalo, M.; Apelqvist, J.; Setacci, C.; Ricco, J.-B.; de Donato, G.; Becker, F.; Robert-Ebadi, H.; Cao, P.; Eckstein, H.H.; De Rango, P.; Diehm, N.; Schmidli, J.; Teraa, M.; Moll, F.L.; Dick, F.; Davies, A.H. (2011). "Chapter V: Diabetic Foot". European Journal of Vascular and Endovascular Surgery. 42: S60–S74. doi:10.1016/S1078-5884(11)60012-9. ISSN 1078-5884.
- ↑ Schaper, N. C.; Andros, G.; Apelqvist, J.; Bakker, K.; Lammer, J.; Lepantalo, M.; Mills, J. L.; Reekers, J.; Shearman, C. P.; Zierler, R. E.; Hinchliffe, R. J. (2012). "Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot". Diabetes/Metabolism Research and Reviews. 28: 218–224. doi:10.1002/dmrr.2255. ISSN 1520-7552.
- ↑ Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM (2001). "Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis". JAMA. 285 (10): 1338–45. doi:10.1001/jama.285.10.1338. PMID 11255390.
- ↑ Prince, Martin R.; Zhang, Honglei; Morris, Michael; MacGregor, Jennifer L.; Grossman, Marc E.; Silberzweig, Jeffrey; DeLapaz, Robert L.; Lee, Henry J.; Magro, Cynthia M.; Valeri, Anthony M. (2008). "Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers". Radiology. 248 (3): 807–816. doi:10.1148/radiol.2483071863. ISSN 0033-8419.
- ↑ Rydahl, Casper; Thomsen, Henrik S.; Marckmann, Peter (2008). "High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent". Investigative Radiology. 43 (2): 141–144. doi:10.1097/RLI.0b013e31815a3407. ISSN 0020-9996.